Plasmacytoid urothelial carcinoma is rare and aggressive, with poor outcomes and challenges in accurate staging. National and institutional data reveal discrepancies in chemotherapy use and disease ...

In this video, Fed Ghali, MD, highlights key findings from the study, “Evaluating Clinical Outcomes and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a ...

Five percent of newly diagnosed patients have metastatic disease. Metastatic urothelial carcinoma (mUC) is primarily treated with cisplatin-based chemotherapy, immunotherapy, targeted therapy, or ...

The National Comprehensive Cancer Network recommends that all patients with stage IVA and stage IVB urothelial carcinoma have molecular analysis that integrates at least FGFR3 testing to help ...

Drug-induced hyponatremia is an adverse reaction with accelerated electrolyte disturbance. This study reported a rare case of delayed hyponatremia in a 68year-old female with recurrent upper tract ...

Objective: To investigate the optimal cut-off value of immunohistochemical marker Ki67 as a prognostic factor to predict the recurrence of non-muscle invasive bladder urothelial carcinoma (NMIBUC).

Other types include squamous cell carcinoma or adenocarcinoma, which develop in the inner lining of the bladder. The proteomic landscape of muscle-invasive bladder cancer (MIBC) in the context of ...

AI decision support system non-homogenously influences clinical decisions in dynamic treatment regimen, as it depends on several factors including prior knowledge, preference, disease type ...

epithelioid and plasmacytoid forms, causing significant diagnostic dilemmas. The coexpression of at least one epithelial marker and S-100 or GFAP protein is required for the diagnosis. Here we report ...

Skin cancer is by far the most common type of cancer in the United States. Merkel cell carcinoma (MCC) is a type of skin cancer, but it's not common. About 3,000 people are diagnosed with Merkel cell ...

Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde ...